Larvol Delta - MasterKey01-A-Study-of-BDTX189-an-Orally-Available-Allosteric-ErbB-Inhibitor-in-Patients-With-Advanced-Solid-Tumors

tuxobertinib (BDTX-189) - Black Diamond Therap

http://clinicaltrials.gov/ct2/show/NCT04209465

Apr 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next